Asian flu by last week had attacked an estimated 400,000 people in the U.S. Though manufacturers were pouring out vaccine far faster than expected (3,700,000 doses last week), there was a serious snarl over who was to get the inoculations and when. With only voluntary priorities suggested by Washington, most of the vaccine (which often caused a slight feverish reaction) so far seemed to have been sold to anyone who went after it early and energetically enough, notably football teams and business concerns.
The Priorities. San Francisco's pro Forty-Niners and the Stanford and...
To continue reading:
or
Log-In
